DigestRedComo funciona
Red
/
Empresas
Po
No verificado

PopVax

Sobre qué escribimos

EventosFarmacéuticaIndustriaSaludVIH, SIDA y enfermedades autoinmunes

3 Comunicados de prensa

Ver todos los comunicados de prensa
13/01/2025
Eventos
Ferias y Congresos
Industria
VIH, SIDA y enfermedades autoinmunes
Farmacéutica
Salud
Medicina - Varios
PopVax is Awarded 2 Million USD as One of the Winners of the BARDA Patch Forward Prize for its Seasonal Influenza Vaccine built on a Novel mRNA-encoded Immunogen Display Architecture Delivered via Dissolvable Microarray Patch
Fuente
PopVax
Editor
Business Wire
1.00
0
13/11/2024
Salud
Sanidad
Ciencia
Farmacéutica
Eventos
Industria
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
Fuente
PopVax
Editor
Business Wire
1.00
0
30/10/2024
Voluntariado/Solidaridad/ONGs
Industria
Mercado laboral
Análisis de Mercados
Asociaciones/Profesionales
Ciencia
Farmacéutica
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Medicina - Varios
Sanidad
Comunicación
Salud
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
Fuente
PopVax
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0